Mon-Fri 9:00-18:00 CET+39 095 7211344info@vitasanlabs.com

Family · Pharmaceutical analytical standards

Montelukast

A leukotriene receptor antagonist approved in 1998, used in tablets for asthma and allergic rhinitis. This family brings together the active ingredient, pharmacopoeial impurities, metabolites, labelled standards and other impurities.

Did you know?The first letters of its name, Mont-, are a tribute to Montreal, the Canadian city where the medicine was developed.

MontelukastGo to the active ingredient →
MontelukastActive ingredientMontelukastCat. No. P-M165-001CAS 158966-92-8
Montelukast-d6Isotopically labelledMontelukast-d6Cat. No. P-M165-019CAS 1093746-29-2

EDQM standards 4

The official European Pharmacopoeia standards for this family.

Need a molecule you cannot find?

Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.